Evolus
EOLS
134 hedge funds and large institutions have $271M invested in Evolus in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 66 increasing their positions, 23 reducing their positions, and 14 closing their positions.
346% more call options, than puts
Call options by funds: $1.65M | Put options by funds: $370K
187% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 23
64% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 14
7% more funds holding
Funds holding: 125 → 134 (+9)
5.17% more ownership
Funds ownership: 60.33% → 65.5% (+5.2%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
6% less capital invested
Capital invested by funds: $289M → $271M (-$17.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$33.9M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$8.77M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$8.12M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$7.99M |
| 5 |
BlackRock
New York
|
+$4.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$30.2M |
| 2 |
First Manhattan
New York
|
-$14.9M |
| 3 |
JFG
Jefferies Financial Group
New York
|
-$4.23M |
| 4 |
Millennium Management
New York
|
-$3.75M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.41M |
EOLS Hedge Fund Activity: Q2 2023 in Review
134 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Evolus (EOLS) for Q2 2023, worth a combined $271M — down 6.1% from $289M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new EOLS positions and 14 closed out — a net gain of 9 holders — while 66 added to existing stakes and 23 trimmed.
The largest buyer was Stonepine Capital Management, adding an estimated $33.9M. The largest seller was Deerfield Management, exiting entirely with an estimated $30.2M sold.
- 134 institutional investors held Evolus (EOLS) as of Q2 2023, up from 125 in Q1 2023.
- Funds reported $271M of Evolus stock for Q2 2023, down 6.1% quarter-over-quarter.
- 23 funds opened new Evolus positions in Q2 2023 and 14 closed out, a net change of +9 holders.
- The largest Evolus buyer in Q2 2023 was Stonepine Capital Management, an estimated $33.9M added.
- The largest Evolus seller in Q2 2023 was Deerfield Management, an estimated $30.2M sold.
Based on aggregated 13F filings for Q2 2023.